MapLight Therapeutics Inc (MPLT) Price Prediction & ForecastMPLTMapLight Therapeutics Inc

Alphio's MPLT stock price prediction model matches the current MapLight Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.00 (-0.46%). The 1-week path is $12.97 (-0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

MapLight Therapeutics, Inc. is a good buy right now due to its current price of $12.6, which is significantly below the recent analyst price target of $25 from Craig-Hallum. The stock has shown a strong recent performance with a 5-day change of +12.40%, indicating positive momentum. However, investors should be cautious of the risk posed by the negative sentiment surrounding the Phase 2 trial results, which have led to downgrades and a projected EPS of -1.32 for the last earnings report, reflecting ongoing financial challenges.

MapLight Therapeutics Inc (MPLT) last closed at $13.06, losing -1.88%. These facts feed the 1-day and 1-week MPLT price prediction above.